» Articles » PMID: 39599685

The Gut Microbiota and Its Metabolites and Their Association with the Risk of Autoimmune Thyroid Disease: A Mendelian Randomization Study

Overview
Journal Nutrients
Date 2024 Nov 27
PMID 39599685
Authors
Affiliations
Soon will be listed here.
Abstract

: Observational research shows associations of the gut microbiota and its metabolites with autoimmune thyroid disease (AITD), but the causality is undetermined. : Two-sample Mendelian randomization (MR) was employed to analyze the association of the gut microbiota and its metabolites with AITD. A total of 119 gut microbiotas and nine fecal/circulating metabolites were the exposures. AITD, Graves' disease (GD), and Hashimoto's thyroiditis (HT) were the outcomes. Inverse-variance weighting (IVW) was primarily used to assess causality; Cochran's Q was used to assess heterogeneity. Sensitivity analyses (weighted median, MRPRESSO regression, MRPRESSO intercept, MRPRESSO global, Steiger filtering, leave-one-out) were conducted to assess causal estimate robustness. Multivariable MR (MVMR) was used to estimate the effects of body mass index (BMI) and alcohol consumption frequency on causality. : The outcomes were potentially causally associated with 22 gut microbiotas and three metabolites. After multiple-test correction, 3-indoleglyoxylic acid retained significant causality with AITD (IVW: odds ratio [OR] = 1.09, 95% confidence interval [CI] = 1.05-1.14, = 2.43 × 10, FDR = 0.009). The sensitivity analyses were confirmatory (weighted median: OR = 1.06, 95% CI = 1.01-1.12, = 0.025; MRPRESSO: OR = 1.09, 95% CI = 1.15-1.14, = 0.001). MVMR revealed no confounding effects on this association (BMI: OR = 1.21, 95% CI =1.08-1.35, = 0.001; drinks/week: OR = 1.22, 95% CI = 1.04-1.43, = 0.014). : MR revealed no significant causal effects of the gut microbiota on the outcomes. However, MR revealed the causal effects of 3-indoleglyoxylic acid on the risk of AITD.

References
1.
Agus A, Planchais J, Sokol H . Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe. 2018; 23(6):716-724. DOI: 10.1016/j.chom.2018.05.003. View

2.
Su X, Zhao Y, Li Y, Ma S, Wang Z . Gut dysbiosis is associated with primary hypothyroidism with interaction on gut-thyroid axis. Clin Sci (Lond). 2020; 134(12):1521-1535. DOI: 10.1042/CS20200475. View

3.
Shi L, Guo M, Shi C, Gao G, Xu X, Zhang C . Distinguishing benign and malignant thyroid nodules using plasma trimethylamine N-oxide, carnitine, choline and betaine. J Cancer Res Clin Oncol. 2024; 150(3):142. PMC: 10951046. DOI: 10.1007/s00432-024-05666-w. View

4.
Hosseinkhani F, Heinken A, Thiele I, Lindenburg P, Harms A, Hankemeier T . The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases. Gut Microbes. 2021; 13(1):1-22. PMC: 7899087. DOI: 10.1080/19490976.2021.1882927. View

5.
Ratajczak W, Ryl A, Mizerski A, Walczakiewicz K, Sipak O, Laszczynska M . Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs). Acta Biochim Pol. 2019; 66(1):1-12. DOI: 10.18388/abp.2018_2648. View